Edition:
United Kingdom

Redhill Biopharma Ltd (RDHL.OQ)

RDHL.OQ on NASDAQ Stock Exchange Global Market

7.00USD
3:34pm GMT
Change (% chg)

$0.02 (+0.29%)
Prev Close
$6.98
Open
$7.02
Day's High
$7.18
Day's Low
$7.00
Volume
19,198
Avg. Vol
37,150
52-wk High
$11.47
52-wk Low
$4.41

Select another date:

Mon, Dec 3 2018

RedHill Biopharma's antibiotic succeeds in late-stage study

Israel-based RedHill Biopharma Ltd said on Monday its combination antibiotic met the main goal of a late-stage study testing the drug in patients with a type of bacterial infection that affects the stomach and small intestine.

UPDATE 1-RedHill Biopharma's antibiotic succeeds in late-stage study

Dec 3 Israel-based RedHill Biopharma Ltd said on Monday its combination antibiotic met the main goal of a late-stage study testing the drug in patients with a type of bacterial infection that affects the stomach and small intestine.

RedHill Biopharma's antibiotic succeeds in late-stage study

Dec 3 Israel-based RedHill Biopharma Ltd said on Monday its combination antibiotic met the main goal of a late-stage study testing the drug in patients with a type of bacterial infection that affects the stomach and small intestine.

RedHill BioPharma has positive results from Crohn's disease trial

TEL AVIV Israel's RedHill Biopharma said on Monday it had positive safety and efficacy results from a late-stage clinical trial with its treatment for Crohn's disease called RHB-104.

RedHill BioPharma has positive results from Crohn's disease trial

TEL AVIV, July 30 Israel's RedHill Biopharma said on Monday it had positive safety and efficacy results from a late-stage clinical trial with its treatment for Crohn's disease called RHB-104.

Select another date: